![]() Chinook Therapeutics Chinook Therapeutics is a biopharmaceutical company that develops precision medicines for kidney diseases. | ![]() Mesoblast Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine. | ||
Founding Date | Founding Date 2013 | Founding Date 2011 | Founding Date 2004 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Philadelphia, US HQ | Locations Seattle, US HQ | Locations Melbourne, AU HQ Singapore, SG New York, US |
Employees | Employees 36817% increase | Employees 27 | Employees 73 |
Valuation ($) | Valuation ($) 4.4 b | Valuation ($) N/A | Valuation ($) 1.2 b |
Financial | |||
Revenue (est.) | Revenue (est.) $64.7m (FY, 2018) | Revenue (est.) $6.1m (FY, 2022) | Revenue (est.) $17.2m (FY, 2025) |
Net income | Net income ($78.8m) (FY, 2018) | Net income ($187.9m) (FY, 2022) | Net income ($102.1m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 122.8m | Total funding raised $ 171m | Total funding raised $ 56.2m |

Chinook Therapeutics is a biopharmaceutical company that develops precision medicines for kidney diseases.
View company
Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine.
View company